GlaxoSmithKline Pharmaceuticals Ltd. (500660.BY) Tuesday said first-quarter net profit rose 13% to INR1.61 billion from INR1.43 billion a year earlier, beating analysts' estimates.

The Indian unit of GlaxoSmithKline PLC (GSK.LN) said net sales in the three months ended March 31 rose 18% to INR5.41 billion from INR4.57 billion.

A Dow Jones Newswires poll of seven analysts had expected a net profit of INR1.42 billion on net sales of INR5.22 billion.

The company didn't immediately provide a reason for the rise in earnings.

By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; rumman.ahmed@dowjones.com

Order free Annual Report for GlaxoSmithKline plc

Visit http://djnweurope.ar.wilink.com/?ticker=GB0009252882 or call +44 (0)208 391 6028

 
 
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.